Menstrual Phase and Postoperative Pain

May 12, 2014 updated by: SINEM SARI, Aydin Adnan Menderes University

The Influence of the Menstrual Cycle on Acute and Persistent Pain After Laparoscopic Cholecystectomy

Fluctuations of female sex hormones during the menstrual cycle influence pain perception. Endogenous pain is pronounced in the follicular phase of the menstrual cycle. The investigators tested the primary hypothesis that the women having surgery during their follicular phase have more acute pain and require more opioids than those in the luteal phase, and secondarily the investigators tested that women who have surgery during their follicular phase have more incisional pain at 3 month postoperatively.

Study Overview

Detailed Description

127 adult females having laparoscopic cholecystectomy were randomized to have surgery during the luteal or follicular phase of their menstrual cycle. Standardized anesthesia and pain management regimen was given to all patients. Pain and analgesic consumption were evaluated in PACU and every four hours in first 24 hours. Adverse effects were also questioned every four hours. Time to oral intake and ambulation were recorded. Post-surgical pain, hospital anxiety and depression scale, and SF-12 questionnaire were also evaluated at 1- and 3-month visits.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aydin, Turkey, 09100
        • Adnan Menderes University Medical Faculty, Anesthesiology and Reanimation Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women with a negative urine pregnancy test

Exclusion Criteria:

  • Patients with pre-existing pain syndromes
  • Patients using routinely using opioids
  • Patients using hormone preparations in the last 6 months
  • Patients with hysterectomy
  • Patients breastfeeding in the previous 6 months
  • Patients with body mass index >35 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: follicular phase
Visual anlogue score vas used to evaluate pain. The anxiety/depression scale (HAD) was used to assess anxiety and depression. The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
Other Names:
  • The anxiety/depression scale
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
Other Names:
  • SHORT FORM 12
Visual analogue score vas used to evaluate pain.
Other Names:
  • VAS score
Active Comparator: luteal phase
Visual anlogue score vas used to evaluate pain. The anxiety/depression scale (HAD) was used to assess anxiety and depression. The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
Other Names:
  • The anxiety/depression scale
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
Other Names:
  • SHORT FORM 12
Visual analogue score vas used to evaluate pain.
Other Names:
  • VAS score

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Persistent surgical pain after laparoscopic cholecystectomy assessed by VAS scale
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
The anxiety and depression was evaluated with Hospital anxiety and depression scale.
Time Frame: 3 months
3 months

Other Outcome Measures

Outcome Measure
Time Frame
Quality of life was evaluated with SF 12 test.
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Betul Kozanhan, Specialist Doctor, Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey
  • Principal Investigator: Ayse Ilksen Egilmez, Specialist Doctor, Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey
  • Principal Investigator: Aykut Soyder, Assistant Professor, Adnan Menderes University Medical Faculty, General Surgery Department, Aydin; Turkey
  • Principal Investigator: Fabrizio Galimberti, Medical Student, Cleveland ClinicLernerCollege of Medicine, Cleveland, Ohio
  • Principal Investigator: Daniel I. Sessler, Professor and Ch, Department of Outcomes Research, Cleveland Clinic
  • Principal Investigator: Alparslan Turan, Associate Professor, Associate Professor of Anesthesiology, Department of Outcomes Research, Cleveland Clinic
  • Principal Investigator: Osman Nuri Aydın, Professor, Adnan Menderes University Medical Faculty, Anesthesiology and Reanimation Department, Aydin; Turkey

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

November 1, 2013

Study Registration Dates

First Submitted

May 12, 2014

First Submitted That Met QC Criteria

May 12, 2014

First Posted (Estimate)

May 13, 2014

Study Record Updates

Last Update Posted (Estimate)

May 13, 2014

Last Update Submitted That Met QC Criteria

May 12, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Postoperative Pain

Clinical Trials on HAD scale

3
Subscribe